3,4-dihydro-2-naphthamide derivatives as selective dopamine D3 ligands
US7875617B2 · kind B2 · utility
0Cited by
3References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2006 |
| Grant date | Jan 25, 2011 |
| Priority date | — |
| Expiry date | Dec 21, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/155
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to 3,4-dihydro-2-naphthamide derivatives of formula (I), pharmaceutical compositions containing them and their therapeutic applications as partial agonists or antagonists of the dopamine D3 receptor for the treatment of neuropsychological disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.